Skip to main content
. Author manuscript; available in PMC: 2016 Nov 10.
Published in final edited form as: Int J Pharm. 2015 Sep 16;495(1):579–587. doi: 10.1016/j.ijpharm.2015.09.028

Figure 1.

Figure 1

(A) Photograph of pod-IVR containing four pods of TDF and one 1 mm diameter delivery channel per pod. Inset shows a close-up of the embedded TDF pod and delivery channel formed during the ring scaffold injection molding process. (B) Cross-sectional diagram of pod-IVR sectioned through the pod showing TDF pod (1) with PVA or PLA coating (2) inserted into a pod cavity in the ring scaffold (4) and sealed in the ring by backfilling the pod cavity with silicone (5). Three delivery channels of diameter d (3) expose the TDF pod to vaginal fluids.